Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) insider Aziz Mottiwala sold 2,400 shares of Tarsus Pharmaceuticals stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $20.05, for a total value of $48,120.00. Following the completion of the sale, the insider now directly owns 45,806 […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Rating) CEO Bobak R. Azamian sold 3,100 shares of the business’s stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $20.01, for a total transaction of $62,031.00. Following the completion of the transaction, the chief executive officer now owns 1,040,006 shares […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Rating) CEO Bobak R. Azamian sold 8,000 shares of the company’s stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $15.90, for a total value of $127,200.00. Following the sale, the chief executive officer now owns 1,043,106 shares of the company’s […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Rating) CEO Bobak R. Azamian sold 9,000 shares of the stock in a transaction on Wednesday, May 10th. The stock was sold at an average price of $16.80, for a total value of $151,200.00. Following the transaction, the chief executive officer now owns 1,051,106 shares in the company, valued […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Rating) CEO Bobak R. Azamian sold 4,278 shares of the stock in a transaction dated Friday, April 28th. The stock was sold at an average price of $15.13, for a total transaction of $64,726.14. Following the transaction, the chief executive officer now directly owns 1,065,947 shares of the company’s […]